WuXi Biologics
Offering End-to-End Solutions
Viral Vaccines GMP Manufacturing
WuXi Vaccines offers extensive capabilities and capacity in the development and GMP manufacturing of live-attenuated viral vaccines and viral vectored vaccines in BSL-2 facilities. GMP production capabilities include single-use bioreactors up to 500 L, oRABS and Isolator technology for fill and finish, and quality control.
DS Manufacturing
Suspension Cell Culture
- Shorter production time: N-1 perfusion in the wave system
- High cell density: Intensified cell culture process
(ATF-based) - Mature scale-up strategy: From bench-scale to 200 L in place, up to 500 L
Adherent Cell Culture Platforms
- A commercially proven platform for live attenuated viral vaccine manufacturing through T-Flask.
- Multi-layer vessels (Cell Factory) enabling scalable production through a parallel and stacked system like Cell Factory.
- Higher efficiency: Perfusion-based microcarrier cell culture in single-use bioreactors
- Higher volumetric titer with a smaller footprint: Fixed-bed bioreactor like iCellis
Manufacturing Capacity for Viral Vaccines
| Facilities | CCS | Unit/Batch Liquid product, 8 hours filling |
Unit/Batch Lyo product |
| DP16 | 2R | 144,000 | 21,920 |
| 10R | 96,000 | 9,490 | |
| 20R | 62,400 | 6,195 | |
| DP17 | 2R | 240,000 | 300,000 |
| 10R | 192,000 | 129,000 | |
| 20R | 114,000 | 84,000 |
SYNTEGON® Automatic Vial Filling Line
- Peristaltic Pump Filling
- Single-Use Filtration and Filling System
- 100% or Statistic Sampling IPC
- oRABS (DP16) and Isolator (DP17) Technology
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?